JetBlue Airways Corporation vs Twist Bioscience Corp — how do they compare? JetBlue Airways Corporation trades at $5.34 (market cap $2.03B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is far larger — about 2.7× JetBlue Airways Corporation's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| JBLU | TWST | |
|---|---|---|
Market Cap | $2.03B | $5.45B |
Sector | Industrials | Health |
52-Week High | $6.46 | $102.88 |
52-Week Low | $4.03 | $24.16 |
Enterprise Value | $9.19B | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →